Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride

Radium-223 dichloride (Ra-223) is the first α-particle emitting radiopharmaceutical to be approved for the treatment of patients with castration-resistant prostate cancer and associated bone metastases, and the first bone-targeting agent to significantly improve patient overall survival whilst reduc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Urol Nurs
Main Authors: Lien, Lise Marie E, Tvedt, Birger, Heinrich, Daniel
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2015
Fag:
Review Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467240/
https://ncbi.nlm.nih.gov/pubmed/26097500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijun.12059
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker